{"id":100066,"date":"2024-10-23T09:03:14","date_gmt":"2024-10-23T09:03:14","guid":{"rendered":"https:\/\/chezaspin.com\/blog\/index.php\/2024\/10\/23\/availability-of-lenacapavir-treatment-in-2025-set-to-transform-global-health-says-cdc-kenyas-director\/"},"modified":"2024-10-23T09:03:14","modified_gmt":"2024-10-23T09:03:14","slug":"availability-of-lenacapavir-treatment-in-2025-set-to-transform-global-health-says-cdc-kenyas-director","status":"publish","type":"post","link":"https:\/\/chezaspin.com\/blog\/availability-of-lenacapavir-treatment-in-2025-set-to-transform-global-health-says-cdc-kenyas-director\/","title":{"rendered":"\u2018Availability Of Lenacapavir Treatment\u00a0 In 2025 Set To Transform Global Health,\u2019 Says CDC Kenya\u2019s Director"},"content":{"rendered":"

KISII, Kenya, Oct 23 \u2013 The U.S Food and Drug Administration ( FDA) has confirmed the availability of \u00a0lenacapavir, a two yearly injectable HIV\/ADS treatment as early as summer 2025, a decision made by FDA after the completion of phase 3 trial of lenacapavir treatment.<\/strong><\/p>\n

In an interview with Capital FM\u00a0 Centers for Disease Control and prevention(CDC) Kenya program \u00a0Director for HIV and TB Dr. Jennifer Galbraith said the U.S Government\u2019s Bureau of Global Health Security and Diplomacy is currently engaging the manufacturer\u00a0 ( Gilead) in ensuring supply of this treatment is contained.<\/p>\n

\u201cThe bureau will ensure pricing level of this treatment for initial introduction is reasonable in the context\u00a0 of value for averted infections,\u201d said Dr.Galbraith.<\/p>\n

She noted the United States President\u2019s Emergency Plan for AIDS Relief (PEPFAR) hopes to ensure a significant supply of this treatment \u00a0to be available for country programs with significant epidemiological need and enabling environment for product introduction.<\/p>\n

In Kenya, PEPFAR has prioritized mapping of unreachable mothers and babies to increase the access of HIV services in health facilities which were traditionally not testing for HIV or offering\u00a0\u00a0 antiretroviral treatment, to bolster Kenya\u2019s action plan of ending AIDS in children by 2027.<\/p>\n

Gilead recently announced making cheaper versions of\u00a0 lenacapavir treatment available in 120 low and middle income countries.<\/p>\n

\u00a0lenacapavir treatment costs up to $40,000 per person per year in the US, a figure that remains too expensive for people in the lower- and middle-income countries in Africa, Asia and Latin America to afford.<\/p>\n

Response to eliminate HIV\/AIDS among children<\/strong><\/p>\n

At least Eight counties (Siaya,Migori, Kisumu, Homa Bay, Nairobi, Kakamega, Bungoma and Nakuru) contribute 50% of the country\u2019s HIV pediatric infections and in response PEPFAR has established country elimination taskforce to oversee\u00a0 Transition from paper registers to electronic medical records for better longitudinal monitoring.<\/p>\n

The taskforce will further support the Partnerships with private health facilities offering antenatal services to integrate HIV testing and treatment, Strengthening supply chain and ensuring uninterrupted commodities.<\/p>\n

\u201cIn additional they will also support \u00a0regular stake holder meetings at national and county levels, Joint planning and monitoring of progress at both national and county level Support formation of national taskforce path to elimination. Aligning services to the community health strategy to increase early identification and referrals by community health promoters,\u201d Said Dr. Galbraith.<\/p>\n

Improving maternal health to eliminate mother-to-child HIV transmission.<\/strong><\/p>\n

US Ambassador to Kenya Meg Whitman while concluding her two day visit to Kisii county\u00a0 applauded\u00a0 the Centers for Disease Control and prevention(CDC) in Kenya and PEPFAR in improving maternal health in Kisii county.<\/p>\n

Speaking at Kisii Teaching and Referral Hospital (KTHRH)\u00a0 the ambassador said the US government is supporting global efforts to eliminate new HIV infections in children, an ambitious goal of ending mother-to-child transmission (MTCT) through various programs including PEPFAR and USAID by 2027.<\/p>\n

\u00a0\u201cwe have seen the HIV clinic which is a product of PERFAR, this is president Bush\u2019s initiative to combat HIV\/AIDS and this clinic is also supported by the CDC and it\u2019s remarkable of what we have done together,\u201d Said Mrs Whitman.<\/p>\n

Whitman further acknowledged the UNAIDS triple zero outcome of zero missed appointments, Zero missed doses and zero missed viral load, an innovation campaign which is spreading country wide in eliminating HIV\/AIDS.<\/p>\n

covid\u2019s disruption of supply chain<\/strong><\/p>\n

\u00a0The ambassador noted, during Covid-19 PEPFAR\u2019s systems and delivery networks turned out to be effective for\u00a0 HIV treatment, tuberculosis and\u00a0 malaria and also combating other diseases.\u201dCovid-19 disrupted retroviral treatment however for the past six months everyone has the retroviral drugs they need including essential drugs by end of the year,\u201d said Whitman<\/p>\n

She noted it\u2019s not a man issue but \u00a0a supply chain, and a lot of supply chains were \u00a0disrupted during covid19 and it\u2019s amazing how long it has taken for production to get back where they are, they rely on Kenyan mechanisms \u00a0in distributing these drugs such as \u00a0KEMSA<\/p>\n

\u201cwe can achieve the goal of ending mother-to-child HIV transmission by 2027 and get beyond the HIV epidemic. I would like to thank you for your dedication and expertise, by listening to us and also giving us room to improve in the fight against the epidemic,\u201d Said Whitman.<\/p>\n

Collaboration with local governments<\/strong><\/p>\n

Kisii governor Simba Arati said as a county the collaboration with the US government is remarkable and they will need more support including modernizing the KTRH hospital.<\/p>\n

\u201cthe mother and child unit is a dream of everyone in this country,we have a good working relation from all the staff in this facility,\u201d Said Arati.<\/p>","protected":false},"excerpt":{"rendered":"

KISII, Kenya, Oct 23 \u2013 The U.S Food and Drug Administration ( FDA) has confirmed the availability of \u00a0lenacapavir, a two yearly injectable HIV\/ADS treatment as early as summer 2025, a decision made by FDA after the completion of phase 3 trial of lenacapavir treatment. In an interview with Capital FM\u00a0 Centers for Disease Control […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-100066","post","type-post","status-publish","format-standard","hentry","category-uncategorized","entry"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/posts\/100066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/comments?post=100066"}],"version-history":[{"count":0,"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/posts\/100066\/revisions"}],"wp:attachment":[{"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/media?parent=100066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/categories?post=100066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/tags?post=100066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}